Pharmaceutical composition for prevention or treatment of cardiac failure
A pharmaceutical composition, a technology for heart failure, applied in the directions of pharmaceutical combinations, pharmaceutical formulations, active ingredients of heterocyclic compounds, etc., can solve problems such as pleural effusion and cardiac hypertrophy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0136] Inhibitory Effects of Carbohydrase Inhibitors on Left Ventricular Hypertrophy
[0137] (1) Animals used
[0138] Rats (Wister, male, nine weeks at the time of use, sold by Japan SLC Co., Ltd.)
[0139] (2) Experimental methods and results
[0140] After anesthesia with pentobarbital (50 mg / kg i.p.), a median incision was made, and the abdominal aorta between the left and right renal arteries was dissected. A 22G injection needle was used to block along the artery, and the injection needle and the artery were ligated with silk thread. Afterwards, the injection needle was pulled out to complete the stenosis of the abdominal aorta, and then the abdomen was closed. In the sham group, the abdomen was closed without ligation. In a powder feed (FR-2 powder feed, manufactured by Funabashi Farm Co., Ltd.), compound A at a concentration of 300 ppm (w / w) and voglibose at a concentration of 20 ppm (w / w) were mixed, resulting in From the second day to the 23rd day of the narrow...
experiment example 2
[0145] Inhibitory Effects of Carbohydrase Inhibitors on Cardiac Hypertrophy Induced by Administering Drugs for Improving Insulin Resistance
[0146] (1) Animals used
[0147] Diabetic mice (BKS.Cg-+Lepr[db] / +Lepr[db] / Jcl, female, 7 weeks at the time of use, sold by Nippon Clear Co., Ltd.)
[0148] (2) Experimental methods and results
[0149] The mice were divided into groups based on blood sugar levels and body weights, and the control group was allowed to freely ingest a powder feed (FR-2 powder feed, manufactured by Funabashi Farm Co., Ltd.) for two weeks. The pioglitazone group and the combined use group were put into the powder feed mixed with pioglitazone at a concentration of 30ppm, and the compound A group and the combined use group were given compound A mixed with 100ppm concentration (w / w) in the powder feed. mixed feed. Blood glucose levels and ventricular muscle weights were measured two weeks after the start of compound administration. Blood was collected from...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com